The company submitted to the health agency all modules required for the evaluation of NVX-CoV2373, its protein-based COVID-19 vaccine, days after receiving...
Without EUA, Covaxin will not be considered an accepted vaccine by most countries around the world. the WHO’s queries for Bharat Biotech...
WHO’s approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be...
The UN health agency’s assessment of the vaccine was “quite advanced” and officials are expecting a decision by mid-September New Delhi: The much-awaited...
The vaccine induced (a) neutralising antibody (an immune response) and was well-tolerated in all dose groups with no vaccine-related serious adverse events...